Captrust Financial Advisors Embecta Corp. Transaction History

Captrust Financial Advisors

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$12.87 - $19.09 $13,526 - $20,063	1,051 Added 6.63%	16,898 $319,000
Q3 2023 Nov 14, 2023	BUY	$15.0 - $22.17 $52,470 - $77,550	3,498 Added 28.33%	15,847 $238,000
Q2 2023 Aug 14, 2023	BUY	$21.6 - $30.69 $33,544 - $47,661	1,553 Added 14.38%	12,349 $266,000
Q1 2023 May 15, 2023	BUY	$23.07 - $32.77 $31,398 - $44,599	1,361 Added 14.43%	10,796 $303,000
Q4 2022 Feb 15, 2023	SELL	$25.29 - $35.48 $27,945 - $39,205	-1,105 Reduced 10.48%	9,435 $238,000
Q3 2022 Nov 16, 2022	BUY	$24.0 - $33.42 $25,080 - $34,923	1,045 Added 11.01%	10,540 $303,000
Q2 2022 Aug 23, 2022	SELL	$24.78 - $33.36 $14,694 - $19,782	-593 Reduced 5.88%	9,495 $240,000
Q2 2022 Aug 16, 2022	BUY	$24.78 - $33.36 $249,980 - $336,535	10,088 New	10,088 $255,000

405

51.1M

162K

61K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $1.17B
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.